Rights and permissions
About this article
Cite this article
Alzheimer’s cost mostly carried by US Medicaid programmes. Pharmacoecon. Outcomes News 210, 11 (1999). https://doi.org/10.1007/BF03274967
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03274967